Thepredominantapproach in cancer therapy involves eradicating tumors through the initiation ofapoptosis.Bcl-2, recognized as an anti-apoptotic member within the Bcl-2 family, serves as akey regulatorof apoptosis. This evidence concerns the gene BCL2 and cancer.